(Q44362500)

2 December 2017

title

CCR5 and its ligands: a new axis of evil? (English)

1 reference

2 December 2017

Michael M Lederman

1

1 reference

2 December 2017

Scott F Sieg

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

2 December 2017

1 reference

2 December 2017

volume

8

1 reference

2 December 2017

issue

12

1 reference

2 December 2017

page(s)

1283-1285

1 reference

Biology of CCR5 and its role in HIV infection and treatment

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

CCR5 deficiency increases risk of symptomatic West Nile virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNI1207-1283

7 January 2021

Identifiers

DOI

10.1038/NI1207-1283

1 reference

2 December 2017

1 reference